Holen Sie sich die Stockscreener-App
27.89
0.39%
-0.11
Handel nachbörslich:
27.90
0.010
+0.04%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
I'm Calling It: Hims & Hers Health Will Soar 56% by the End of 2026 - Yahoo Finance
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - The Journal Gazette
Hims & Hers Stock Faces a Margin Test Just as Its Legal Troubles Mount. Here’s What Every Investors Need to Know. - TIKR.com
Kaplan Fox Urges Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm Before the Deadline on November 2, 2026 - NewMediaWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Connect - ACCESS Newswire
Kaplan Fox Urges Hims & Hers Health, Inc. (NYSE: HIMS) Investors - The National Law Review
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock DeclineInvestors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC - PR Newswire
Hims & Hers Health, Inc. (HIMS) Securities Fraud Class Action Lawsuit Filed; November 2, 2026, Lead Plaintiff Deadline - Morningstar
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman, LLC (HIMS) And Encourages Investors to Reach Out - ACCESS Newswire
JPMorgan Tweaks Hims & Hers Stock Outlook on Key Risk - TradingView
DEADLINE ALERT for YSS, HIMS, UNCY, and PZZA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - The Daily Tribune News
DEADLINE ALERT for YSS, HIMS, UNCY, and PZZA: The Law - GlobeNewswire
HIMS Looks 38.5% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
HIMS Assumes Neutral Rating by JP Morgan -- Price Target Announced at $32 - GuruFocus
Hims & Hers Health faces class action over alleged website tracking - Top Class Actions
JPMorgan cautious on Hims & Hers on GLP-1 transition risk By Investing.com - Investing.com South Africa
Hims & Hers Health resumed at JP Morgan at neutral on GLP-1 compounding headwinds - Seeking Alpha
Price-Driven Insight from (HIMS) for Rule-Based Strategy - Stock Traders Daily
Analyst recommendations: Hims & Hers, Adobe, MongoDB… - marketscreener.com
Kaplan Fox Announces a Securities Class Action Filed Against Hims & Hers Health, Inc. (NYSE: HIMS)Lead Plaintiff Deadline is November 2, 2026 - NewMediaWire
HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - The Daily Tribune News
Hims & Hers Health, Inc. (HIMS) Stock Price & News - Syfe
Hims & Hers Health, Inc. (HIMS) Class Action Lawsuit Seeks - GlobeNewswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Hims & - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, - GlobeNewswire
Kaplan Fox Continues to Remind Hims & Hers Health, Inc. (NYSE: HIMS) Investors of the Lead Plaintiff Deadline on November 2, 2026 - NewMediaWire
Faruqi & Faruqi, LLP Urges Hims & Hers Health, Inc. (HIMS) Invest - The National Law Review
HIMS & HERS HEALTH, INC. INVESTORS WITH LOSSES HAVE UNTIL - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Hims & Hers Health, Inc. Investors - GlobeNewswire
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on November 2, 2026 Against Hims & Hers Health, Inc. (NYSE: HIMS) - newmediawire.com
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Reach Out - ACCESS Newswire
Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit Before November 2, 2026 Deadline - PR Newswire
Deadline Alert: Hims & Hers Health, Inc. (HIMS) - GlobeNewswire
Hims & Hers Health, Inc. • Robinhood Token (HIMS) Preț Azi - Bybit
HIMS Class Action Reminder – Robbins LLP Reminds Investors - GlobeNewswire
Is FTC Lawsuit Altering The Investment Case For Hims Stock (HIMS)? - simplywall.st
Why Is Hims & Hers Health (HIMS) Down 7.7% Since Last Earnings Report? - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Regulatory Scrutiny and AI Potential - Quiver Quantitative
Hims & Hers Health, Inc. • Robinhood Token (HIMS) Price Prediction for 2026 to 2031 - bybit.com
Kaplan Fox Continues to Alert Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Class Action Deadline on November 2, 2026 - NewMediaWire
Hims & Hers Health, Inc. Securities Fraud Class Action - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know - Yahoo Finance
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors Seeking Recovery to Contact the Firm Before November 2, 2026 - NewMediaWire
Hims & Hers stock: growth momentum versus margin pressure and a 20.6% fair value discount - Investing.com Canada
Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Kaplan Fox Encourages Wix.com Ltd. (NASDAQ: WIX) Investors with Significant Losses to Contact the Firm Before September 22, 2026 - GlobeNewswire Inc.
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS - PR Newswire
Here's Why Teladoc's Integrated Care Business Deserves More Attention - TradingView
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Hims & Hers Health, Inc. (HIMS) and Encourages Investors to Learn More About the Investigation | NYSE:HIMS | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - PR Newswire
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Inves - The National Law Review
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investo - GuruFocus
INVESTOR DEADLINE ALERT: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Morningstar
HIMS Stock Kicks Off September In The Red: FDA’s GLP-1 Alert Steals The Spotlight From Australia Expansion - Stocktwits
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc.HIMS - Morningstar
Kaplan Fox Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026 - NewMediaWire
ROSEN, LEADING TRIAL COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - ACCESS Newswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Hims & Hers - GlobeNewswire
DEADLINE ALERT for YSS, HIMS, and UNCY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - WBOC TV
Hims & Hers stock price is surging today. A surprising deal with Novo Nordisk is the reason why - Fast Company
Investor relations - HIMS investor relations
1.39%
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):